Abstract
Dibekacin, a new parenteral aminoglycoside, was compared with gentamicin in vitro against 221 clinical isolates. Tests for minimum inhibitory concentrations, performed in agar, demonstrated that dibekacin was comparable to gentamicin against most isolates tested. Dibekacin was slightly more active than gentamicin against some isolates of Pseudomonas aeruginosa, but was significantly less active against strains of Serratia.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Brzezinska M., Benveniste R., Davies J., Daniels P. J., Weinstein J. Gentamicin resistance in strains of Pseudomonas aeruginosa mediated by enzymatic N-acetylation of the deoxystreptamine moiety. Biochemistry. 1972 Feb 29;11(5):761–765. doi: 10.1021/bi00755a013. [DOI] [PubMed] [Google Scholar]
- Counts G. W., Gregory D., Zeleznik D., Turch M. Cefazaflur, a new parenteral cephalosporin: in vitro studies. Antimicrob Agents Chemother. 1977 Apr;11(4):708–711. doi: 10.1128/aac.11.4.708. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mitsuhashi S., Kobayashi F., Yamaguchi M. Enzymatic inactivation of gentamicin C components by cell-free extract from Pseudomonas aeruginosa. J Antibiot (Tokyo) 1971 Jun;24(6):400–401. doi: 10.7164/antibiotics.24.400. [DOI] [PubMed] [Google Scholar]
- Paradelis A. G., Douboyas J., Stathopoulos G., Grigoriadou-Edipides A., Triantaphylidis C., Papapanagiotou J. In vitro comparison of kanamycin, kanendomycin, gentamicin, amikacin, sisomicin, and dibekacin against 200 strains of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1978 Sep;14(3):514–515. doi: 10.1128/aac.14.3.514. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Umezawa H., Okanishi M., Kondo S., Hamana K., Utahara R., Maeda K., Mitsuhashi S. Phosphorylative inactivation of aminoglycosidic antibiotics by Escherichia coli carrying R factor. Science. 1967 Sep 29;157(3796):1559–1561. [PubMed] [Google Scholar]
- Umezawa H., Umezawa S., Tsuchiya T., Okazaki Y. 3',4'-dideoxy-kanamycin B active against kanamycin-resistant Escherichia coli and Pseudomonas aeruginosa. J Antibiot (Tokyo) 1971 Jul;24(7):485–487. doi: 10.7164/antibiotics.24.485. [DOI] [PubMed] [Google Scholar]